Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Early Hum Dev. 2014 Jul 11;90(10):695–701. doi: 10.1016/j.earlhumdev.2014.06.009

Table 1.

CMRO2 values reported in literature.

Study Method Number of
subjects
Gestational
age (weeks)
Subject
condition
Yv (%) CBF
(ml/100g/min)
CMRO2
(μmol/100g/min)
Skov et al, 1993 [13] NIRS 32 26 – 39 Asphyxiated; RDS 53.44±15.36 (preterm) 12.6±6.4 (preterm) 44.7±17.9 (preterm)
67.30±9.38 (term) 26.5±17.9 (term) 62.6±35.8 (term)
Altman et al, 1993 [9] PET 11 26 – 41 HIE and other conditions - 21.6±21.0 21.4±16.4
Yoxall and weindling, 1998 [14] NIRS 20 24 – 41 Seizure and other conditions 64.6 (76.1 – 46.8) 9.3 (4.5 – 28.3) 23.1 (8.6 – 78.5)
Elwell et al, 2005 [12] NIRS 9 23 – 37 Ventilatory support - - 45.9±12.3
Liu et al, 2014[24] MRI 12 35 – 42 Healthy 62.6±8.3 13.4±4.2 38.3±17.7
Jain et al, 2014[33] MRI 33 38 – 40 CHD 55.2 (49.3 – 60.2) 9.7 (7.5 – 15.1) 23.2 (17.8 – 35.2)
De Vis et al, 2014[32] MRI 51 28 – 52 Healthy, HIE and other diagnosis 52±12 (healthy) 14±3 (healthy) 30±6 (healthy)
65±13 (HIE) 12±4 (HIE) 24±12 (HIE)

NIRS, near infrared spectroscopy; PET, positron emission tomography; MRJ, magnetic resonance imaging; RDS, Respiratory distress syndrome; HIE, Hypoxic-ischemic encephalopathy; CHD, Congenital heart disease.